Related by context. Frequent words. (Click for all words.) 65 Poly ICR 64 Azedra 64 Presents Positive 64 Daclizumab 63 URG# 63 therapeutic monoclonal antibodies 63 CPL Biologicals 63 BEMA TM Fentanyl 63 Octreotide 63 vosaroxin 63 Orphan Drug status 63 IND submission 63 Mipomersen 63 Cethromycin 62 Allovectin 7 R 62 siRNA therapeutics 62 ThermoDox R 62 SAR# [004] 62 Panzem R 62 ASONEP 62 Icatibant 62 BEMA Buprenorphine 62 deforolimus 62 Kuvan R 62 forodesine 62 INTERCEPT red 62 BEMA Fentanyl 62 Veronate 62 Onalta 61 Entereg R 61 Tesetaxel 61 MOZOBIL 61 Juvaris 61 GVAX R 61 R sorafenib tablets 61 RNAi Therapeutics 61 Celator 61 novel antibody therapeutics 61 Phase Ib II 61 Phase III Clinical Trial 61 ImmunoCellular Therapeutics 61 Inc Therapeutic Competitors 61 Factor VIIa 61 faropenem 61 Clonicel 61 Hepatitis C Virus HCV 61 DDP# 61 IIa trial 61 ALN TTR# 61 topical anti infective 61 multi kinase inhibitor 60 liposomal formulation 60 Initiate Phase 60 eniluracil 60 registrational trial 60 Nanotherapeutics 60 Phase IIb trials 60 nicotinic alpha 7 60 refractory chronic lymphocytic 60 Microplasmin 60 KNS # 60 Argatroban 60 Pirfenidone 60 targeting CD# 60 Shigamabs ® 60 IMC #B 60 Addrenex 60 Urocidin 60 Golimumab 60 Shigamabs R 60 talactoferrin 60 Pervasis 60 novel RNAi therapeutics 60 anticancer compound 60 confirmatory Phase III 60 Promedior 60 Cetrorelix 60 FDA Accepts 60 Metastatic Melanoma 60 NEUMUNE 60 BLA submission 59 JAK1 59 Pivotal Phase III 59 ZFP Therapeutic 59 Aerosurf 59 PEG SN# 59 elotuzumab 59 HCV protease inhibitor 59 cancer immunotherapies 59 CR# vcMMAE 59 Junovan 59 KRN# 59 Elusys 59 PMA submission 59 Belimumab 59 injectable formulation 59 WILEX 59 IND enabling 59 Clofarabine 59 Fibrillex TM 59 Phase IIB